IKK:Biophysical basis of dynamic regulation
IKK:动态调节的生物物理基础
基本信息
- 批准号:8463406
- 负责人:
- 金额:$ 50.65万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2009
- 资助国家:美国
- 起止时间:2009-07-01 至 2015-05-31
- 项目状态:已结题
- 来源:
- 关键词:AccountingAdverse effectsAffectAnalytical CentrifugationArchitectureArthritisAtherosclerosisBindingBinding SitesBiochemicalBiochemical ReactionBiochemistryBiological AssayBiophysicsCatalytic DomainCell LineCell Surface ReceptorsCellsCharacteristicsChronicChronic DiseaseComplexComputer SimulationCoupledCrystallographyDevelopmentDiseaseDissociationDoseDrug TargetingEffectivenessEnzymesEquationEstimation TechniquesFamilyFeedbackGenesGeneticGoalsHalf-LifeHeat-Shock Proteins 90Human PathologyIkappaB kinaseImmuneImmune responseIn VitroInflammatoryInflammatory ResponseInterleukin-1InterventionKineticsLesionLibrariesMalignant Epithelial CellMalignant NeoplasmsMapsMass Spectrum AnalysisMeasuresMediatingMethodologyModelingMolecularMolecular ChaperonesMonitorMultienzyme ComplexesNF-kappa BNatural regenerationNeoplasm MetastasisNucleotidesOutcomePathogenesisPathologyPathway interactionsPeptide HydrolasesPharmaceutical PreparationsPharmacological TreatmentPhosphoric Monoester HydrolasesPhosphorylationPhosphorylation SitePhosphotransferasesPhysiologicalPhysiologyPlayProtein DephosphorylationProtein KinaseProtein Phosphatase 2A Regulatory Subunit PR53ProteinsReactionReceptor CellReceptor Down-RegulationRecyclingRegulationReportingRestRoleScaffolding ProteinSignal TransductionSignaling ProteinSpecificitySquamous cell carcinomaStimulusStreamStructureStructure-Activity RelationshipStudy modelsTNF geneTestingTherapeuticTherapeutic InterventionTumor Necrosis Factor ReceptorWorkautocrinebasecancer cellcancer typecell typecrosslinkcytokinedesignhigh throughput screeningimmune activationin vivoinhibitor/antagonistmathematical modelmutantnovelparacrinereaction ratereceptorreconstitutionresearch studyresponseself assemblysimulationsmall moleculesrc-Family Kinasestext searchingtranscription factorubiquitin ligaseupstream kinase
项目摘要
IKK is the major signaling hub for inflammatory and innate immune responses. It is an enzyme complex that
receives signals from a large number of cellular receptors regulates that activity of the NF-kB family of transcription
factors. Misregulation of IKK is associated with many chronic diseases, such as chronic inflammatory pathologies
(arthritis, atherosclerosis, etc) and many different types of cancer. Genetic evidence strongly supports IKK's critical
and central role in many functions in physiology and pathology, but its potential as a drug target has not been
realized. Mechanistic and biophysical studies have been lacking, and we have neither a kinetic understanding of
IKK regulation nor structural information. However, what is clear is that IKK mediates signaling specificity by tight
dynamic control that is stimulus-specific and induces the expression of specific sets of genes. Recent studies have
reported on a tightly coupled activation and inactivation mechanism that can only be described by a multi-state
activation-inactivation cycle that involves the function of several enzymes with different functions, such as ubiquitin
ligases, kinases, phosphatases, and foldases. Through regulation of these activities, we hypothesize that the IKK
cycle is driven in a stimulus- and cell type-specific manner, and that understanding the kinetic relationships will
reveal opportunities for rationally targeted pharmacological intervention that discriminate between disease
associated misregulation and stimulus-responsive regulation in healthy cells.
In this proposal, we will construct a mathematical model of the IKK cycle to explore the dynamic regulation of IKK
activity. We will then focus biochemical and biophysical studies on specific control mechanisms. In particular, we
test the roles of IKK oligomerization, conformational changes, and upstream kinases in IKK activation and inhibition
of IKK. Computational simulations will guide genetic and pharmacological manipulation of IKK dynamics. Finally, we
will focus our study on how TNF and IL-1 produce differential dynamic control of IKK; how differential dose response
and temporal control determine the efficacy of cytokine traps.
IKK是炎症和先天免疫反应的主要信号枢纽。这是一种酶复合物
来自大量细胞受体的信号调节NF-KB转录家族的活性
因素。 IKK的正调与许多慢性疾病有关,例如慢性炎症病理学
(关节炎,动脉粥样硬化等)和许多不同类型的癌症。遗传证据强烈支持IKK的关键
在生理和病理学中许多功能中的核心作用,但其作为药物靶标的潜力并非
实现。机械和生物物理研究一直缺乏,我们既不具有对
IKK监管或结构信息。但是,很明显,IKK通过紧密介导信号特异性
刺激特异性的动态控制并诱导特定基因集的表达。最近的研究
报道了只能由多状态描述的紧密耦合激活和灭活机制
激活灭活周期涉及几种具有不同功能的酶的功能,例如泛素
连接酶,激酶,磷酸酶和折叠酶。通过调节这些活动,我们假设IKK
循环以刺激和细胞类型特异性的方式驱动,并且理解动力学关系将
揭示了理性靶向药理学干预的机会,以区分疾病
健康细胞中相关的不调节和刺激反应性调节。
在此提案中,我们将构建IKK周期的数学模型,以探索IKK的动态调节
活动。然后,我们将将生化和生物物理研究集中在特定的控制机制上。特别是我们
测试IKK寡聚,构象变化和上游激酶在IKK激活和抑制中的作用
ikk。计算模拟将指导IKK动力学的遗传和药理学操纵。最后,我们
将把我们的研究集中在TNF和IL-1如何产生IKK的差异动态控制上;差异剂量反应如何
时间控制决定了细胞因子陷阱的功效。
项目成果
期刊论文数量(3)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Probing kinase activation and substrate specificity with an engineered monomeric IKK2.
- DOI:10.1021/bi401551r
- 发表时间:2014-04-01
- 期刊:
- 影响因子:2.9
- 作者:Hauenstein AV;Rogers WE;Shaul JD;Huang DB;Ghosh G;Huxford T
- 通讯作者:Huxford T
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
GOURISANKAR GHOSH其他文献
GOURISANKAR GHOSH的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('GOURISANKAR GHOSH', 18)}}的其他基金
Suppressing Inflammation by Blocking IKK Oligomer
通过阻断 IKK 寡聚物抑制炎症
- 批准号:
10446098 - 财政年份:2022
- 资助金额:
$ 50.65万 - 项目类别:
Suppressing Inflammation by Blocking IKK Oligomer
通过阻断 IKK 寡聚物抑制炎症
- 批准号:
10573218 - 财政年份:2022
- 资助金额:
$ 50.65万 - 项目类别:
Investigation of Gene Regulation by NF-kappaB Transcription factors
NF-kappaB 转录因子基因调控的研究
- 批准号:
8260199 - 财政年份:2009
- 资助金额:
$ 50.65万 - 项目类别:
Investigation of gene regulation by NF-kappaB transcription factors
NF-κB转录因子基因调控的研究
- 批准号:
9021868 - 财政年份:2009
- 资助金额:
$ 50.65万 - 项目类别:
Investigation of gene regulation by NF-kappaB transcription factors
NF-κB转录因子基因调控的研究
- 批准号:
8904029 - 财政年份:2009
- 资助金额:
$ 50.65万 - 项目类别:
Cofactor-Mediated DNA Binding by the NF-kappaB Dimers
NF-kappaB 二聚体辅助因子介导的 DNA 结合
- 批准号:
9887959 - 财政年份:2009
- 资助金额:
$ 50.65万 - 项目类别:
相似国自然基金
基因与家庭不利环境影响儿童反社会行为的表观遗传机制:一项追踪研究
- 批准号:
- 批准年份:2020
- 资助金额:58 万元
- 项目类别:面上项目
不利地质结构对地下洞室群围岩地震响应影响研究
- 批准号:51009131
- 批准年份:2010
- 资助金额:20.0 万元
- 项目类别:青年科学基金项目
列车制动力对铁路桥梁的作用机理及最不利影响的研究
- 批准号:50178004
- 批准年份:2001
- 资助金额:23.0 万元
- 项目类别:面上项目
相似海外基金
Multifunctional Nanoparticle Platform to Prevent Alcohol-Associated HCC Development
多功能纳米颗粒平台可预防酒精相关的 HCC 发展
- 批准号:
10736984 - 财政年份:2023
- 资助金额:
$ 50.65万 - 项目类别:
Reproductive history and later-life brain health: The Bogalusa Heart Study
生殖史和晚年大脑健康:Bogalusa 心脏研究
- 批准号:
10736169 - 财政年份:2023
- 资助金额:
$ 50.65万 - 项目类别:
Neural and Renal Contributions to Hypertension with Androgen Deprivation Therapy
雄激素剥夺疗法对高血压的神经和肾脏影响
- 批准号:
10662133 - 财政年份:2023
- 资助金额:
$ 50.65万 - 项目类别:
Physical Frailty and Symptom Monitoring and Management Behaviors in Heart Failure (PRISM-HF)
心力衰竭的身体虚弱和症状监测和管理行为 (PRISM-HF)
- 批准号:
10740609 - 财政年份:2023
- 资助金额:
$ 50.65万 - 项目类别:
Impact of Structural Racism on Racial Disparities in Cognitive Impairment
结构性种族主义对认知障碍种族差异的影响
- 批准号:
10572864 - 财政年份:2023
- 资助金额:
$ 50.65万 - 项目类别: